Bristol-Myers Squibb Company Ce revenue growth has been varied year-over-year.

What is CELG-RI's revenue growth rate?

Historical revenue data is available for Bristol-Myers Squibb Company Ce to analyze growth trends.

How fast is CELG-RI earnings growing?

Earnings growth data is available for Bristol-Myers Squibb Company Ce analysis.

What is CELG-RI's profit margin?

Profit margin data is available for Bristol-Myers Squibb Company Ce.

CELG-RI Revenue & Earnings Growth Analysis 2026 - Is Bristol-Myers Squibb Company Ce Growing?

Growth Summary

Bristol-Myers Squibb Company Ce (CELG-RI) has experienced challenges in growth. The company operates in the Technology sector, specifically in the Software industry.

Over the past 4 years, Bristol-Myers Squibb Company Ce has achieved a revenue compound annual growth rate (CAGR) of 44.5%, while earnings have grown at -2.8% CAGR.

Latest Revenue

$48.30B

Net Income

$-8933000000.00

5-Year Revenue CAGR

44.5%

4 years of data

Net Margin

N/A

Latest period

Revenue Growth Over Time

Historical revenue and profitability trends for Bristol-Myers Squibb Company Ce

The chart above illustrates Bristol-Myers Squibb Company Ce's revenue trajectory over the past 4 years. The revenue pattern shows the challenges the company has faced in recent periods.

Year-over-Year Growth Rates

Annual percentage change in revenue and earnings

Growth rates provide insight into the momentum of Bristol-Myers Squibb Company Ce's business.

Profit Margin Trends

How efficiently Bristol-Myers Squibb Company Ce converts revenue into profit

Understanding Profit Margins

Profit margins reveal how much of each dollar of revenue Bristol-Myers Squibb Company Ce retains at different stages:

Gross Margin (N/A%): What remains after direct production costs
Operating Margin (N/A%): Profit from core operations before interest and taxes
Net Margin (N/A%): Final profit after all expenses

Future Growth Outlook

Analyst estimates and forward-looking indicators

What Analysts Are Saying

Wall Street analysts project Bristol-Myers Squibb Company Ce to continue focusing on sustainable operations.

Growth Analysis Conclusion

Based on our comprehensive analysis, Bristol-Myers Squibb Company Ce (CELG-RI) demonstrates declining growth characteristics.

Key Takeaways:

Revenue Growth:, 44.5% CAGR over 4 years
Profitability: shows the company is investing in growth over short-term profits
Efficiency:

Investment Considerations

This growth analysis provides a comprehensive view of Bristol-Myers Squibb Company Ce's historical performance and future outlook. Investors should consider these growth metrics alongside valuation, competitive positioning, and broader market conditions when making investment decisions. Past performance does not guarantee future results.